Tarsus Pharmaceuticals TARS
NASDAQ TARS
$75.46 -3.15 (-4.01%)
At close: Oct 1, 2026 · 4:00 PM EDT

Tarsus Pharmaceuticals (TARS) Preferred Stock Liabilities (2019 - 2020)

Updated

Tarsus Pharmaceuticals (TARS) posted Preferred Stock Liabilities of $103.16 million for Q3 2020, compared with $3.56 million a year earlier and up 62.7% from the prior quarter.

Analysis

Tarsus Pharmaceuticals (TARS) Preferred Stock Liabilities (2019 - 2020) Analysis & Trends

At the end of FY2019, Tarsus Pharmaceuticals' Preferred Stock Liabilities came in at $63.4 million.

  • According to Business Quant data, Preferred Stock Liabilities for the three prior quarters was $63.4 million (Q2 2020), $63.4 million (Q1 2020) and $63.4 million (Q4 2019).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Preferred Stock Liabilities (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn -
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn -
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn -
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn -
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn -
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn -
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn -
10 Tarsus Pharmaceuticals 3.40 Bn 2.35 Bn 161.80 Mn -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2020 103.16 Mn
Jun 30, 2020 63.40 Mn
Mar 31, 2020 63.40 Mn
Dec 31, 2019 63.40 Mn
Sep 30, 2019 3.56 Mn
API Access

Tarsus Pharmaceuticals Preferred Stock Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=preferred-stock-liabilities&ticker=TARS&period=max&api_key=YOUR_API_KEY